Log In
Print
BCIQ
Print
Print this Print this
 

Malaria vaccine

  Manage Alerts
Collapse Summary General Information
Company iBio Inc.
DescriptionMalaria vaccine based on a portion of the Pfs230 antigen from Plasmodium falciparum developed using iBioLaunch technology
Molecular Target
Mechanism of ActionVaccine
Latest Stage of DevelopmentPreclinical
IndicationMalaria
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today